Sensyne Health Competitors

Sensyne Health (LON:SENS) and Telecom Plus (LON:TEP) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends and profitability.

Valuation and Earnings

This table compares Sensyne Health and Telecom Plus' gross revenue, earnings per share and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than Telecom Plus, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent recommendations for Sensyne Health and Telecom Plus, as provided by MarketBeat.

Sensyne Health currently has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Telecom Plus has a consensus target price of GBX 1,425, suggesting a potential upside of 13.64%. Given Sensyne Health's stronger consensus rating and higher probable upside, equities analysts clearly believe Sensyne Health is more favorable than Telecom Plus.

Profitability

This table compares Sensyne Health and Telecom Plus' net margins, return on equity and return on assets.

Summary

Sensyne Health beats Telecom Plus on 4 of the 7 factors compared between the two stocks.

XP Power (LON:XPP) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, analyst recommendations, profitability, valuation, dividends and institutional ownership.

Analyst Recommendations

This is a breakdown of recent ratings for XP Power and Sensyne Health, as reported by MarketBeat.

XP Power currently has a consensus price target of GBX 5,498.33, suggesting a potential upside of 13.37%. Sensyne Health has a consensus price target of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's higher probable upside, analysts clearly believe Sensyne Health is more favorable than XP Power.

Profitability

This table compares XP Power and Sensyne Health's net margins, return on equity and return on assets.

Earnings and Valuation

This table compares XP Power and Sensyne Health's revenue, earnings per share (EPS) and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than XP Power, indicating that it is currently the more affordable of the two stocks.

Summary

XP Power beats Sensyne Health on 4 of the 6 factors compared between the two stocks.

Codemasters Group (LON:CDM) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk.

Profitability

This table compares Codemasters Group and Sensyne Health's net margins, return on equity and return on assets.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Codemasters Group and Sensyne Health, as reported by MarketBeat.

Codemasters Group currently has a consensus target price of GBX 446.80, suggesting a potential downside of 25.78%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts clearly believe Sensyne Health is more favorable than Codemasters Group.

Valuation and Earnings

This table compares Codemasters Group and Sensyne Health's top-line revenue, earnings per share (EPS) and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than Codemasters Group, indicating that it is currently the more affordable of the two stocks.

Summary

Codemasters Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.

Team17 Group (LON:TM17) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Valuation & Earnings

This table compares Team17 Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than Team17 Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Team17 Group and Sensyne Health's net margins, return on equity and return on assets.

Analyst Ratings

This is a summary of current recommendations for Team17 Group and Sensyne Health, as provided by MarketBeat.com.

Team17 Group currently has a consensus target price of GBX 778.25, suggesting a potential upside of 17.03%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts plainly believe Sensyne Health is more favorable than Team17 Group.

Summary

Team17 Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.

EMIS Group (LON:EMIS) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Earnings and Valuation

This table compares EMIS Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares EMIS Group and Sensyne Health's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for EMIS Group and Sensyne Health, as provided by MarketBeat.

Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's higher possible upside, analysts plainly believe Sensyne Health is more favorable than EMIS Group.

NCC Group (LON:NCC) and Sensyne Health (LON:SENS) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

Profitability

This table compares NCC Group and Sensyne Health's net margins, return on equity and return on assets.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for NCC Group and Sensyne Health, as provided by MarketBeat.

NCC Group presently has a consensus target price of GBX 236.75, suggesting a potential downside of 8.41%. Sensyne Health has a consensus target price of GBX 310, suggesting a potential upside of 96.83%. Given Sensyne Health's stronger consensus rating and higher possible upside, analysts plainly believe Sensyne Health is more favorable than NCC Group.

Earnings and Valuation

This table compares NCC Group and Sensyne Health's gross revenue, earnings per share (EPS) and valuation.

Sensyne Health is trading at a lower price-to-earnings ratio than NCC Group, indicating that it is currently the more affordable of the two stocks.

Summary

NCC Group beats Sensyne Health on 4 of the 7 factors compared between the two stocks.